ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor
Clinical trial NCT04216563 · TERMINATED
Trial details
- NCT number
- NCT04216563
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2025-03-17
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.